Does My Patient with Multiple Comorbidities Have Heart Failure with Preserved Ejection Fraction, and Does It Matter?

References

1. 1.↵
   1. Yancy CW,
   2. Jessup M,
   3. Bozkurt B,
   4. et al

   . 2013 ACCF/AHA guideline for the management of heart failure: executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013;128:1810–52.

   OpenUrlFREE Full Text
2. 2.↵
   1. Obokata M,
   2. Kane G,
   3. Reddy Y,
   4. Olson T,
   5. Melenovsky V,
   6. Borlaug B

   . The role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: An invasive-echocardiographic study. J Am Coll Cardiol 2017;69:879.

   OpenUrlCrossRef
3. 3.↵
   1. Shah SJ,
   2. Gheorghiade M

   . Heart failure with preserved ejection fraction: Treat now by treating comorbidities. JAMA 2008;300:431–3.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Denolin H,
   2. Kuhn H,
   3. Krayenbuehl HP,
   4. Loogen F,
   5. Reale A

   . The definition of heart failure. Eur Heart J 1983;4:445–8.

   OpenUrlPubMedWeb of Science
5. 5.↵
   1. Reddy YNV,
   2. Carter RE,
   3. Obokata M,
   4. Redfield MM,
   5. Borlaug BA

   . a simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation 2018;138:861–70.

   OpenUrl
6. 6.↵
   1. Thibodeau JT,
   2. Drazner MH

   . The role of the clinical examination in patients with heart failure. JACC Heart Fail 2018;6:543–51.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Adamson PB,
   2. Abraham WT,
   3. Bourge RC,
   4. et al

   . Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail 2014;7:935–44.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Hsu JJ,
   2. Ziaeian B,
   3. Fonarow GC

   . Heart failure with mid-range (borderline) ejection fraction: Clinical implications and future directions. JACC Heart Fail 2017;5:763–71.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Ponikowski P,
   2. Voors AA,
   3. Anker SD,
   4. et al

   . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129–200.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Vaidya GN,
    2. Abramov D

    . Echocardiographic evaluation of diastolic function is of limited value in the diagnosis and management of HFpEF. J Card Fail 2018;24:392–6.

    OpenUrl
11. 11.↵
    1. Nagueh SF,
    2. Smiseth OA,
    3. Appleton CP,
    4. et al

    . Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016;29:277–314.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Redfield MM,
    2. Jacobsen SJ,
    3. Burnett JC,
    4. et al

    . Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 2003;289:194–202.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Abhayaratna WP

    . Characteristics of Left Ventricular Diastolic Dysfunction In The Community: an Echocardiographic Survey. Heart 2006;92:1259–64.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. van Mourik Y,
    2. Rutten FH,
    3. Moons KG,
    4. Bertens LC,
    5. Hoes AW,
    6. Reitsma JB

    . Prevalence and underlying causes of dyspnoea in older people: A systematic review. Age Ageing 2014;43:319–26.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Packer M

    . Questioning the obvious: does dyspnoea really matter in heart failure? Eur Heart J 2018;39:2822–4.

    OpenUrl
16. 16.↵
    1. Solomon SD,
    2. Claggett B,
    3. Lewis EF,
    4. et al

    . Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J 2016;37:455–62.

    OpenUrlCrossRefPubMed